Skip to main content

Table 1 Antimicrobial susceptibility of B.melitensis

From: In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015

 

Range (mg/L)

MIC50 (mg/L)

MIC90 (mg/L)

Breakpoints for susceptibility (mg/L)

Doxycycline

0.032–1

0.125

0.25

≤1 [7]

Tetracycline

0.032–0.5

0.125

0.25

≤ 1 [7]

Gentamicin

0.064–2

0.25

0.5

≤ 4 [7]

Streptomycin

0.125–4

0.5

2

≤ 8 [7]

Trimethoprim-Sulfamethoxazole

0.008–2

0.064

0.25

≤ 2/38 [7]

Rifampicin

0.008–4

1

2

≤ 1 [8]

Ciprofloxacin

0.064–0.5

0.25

0.5

≤ 1 [8]